Using Biologics to Manage Moderate to Severe Atopic Dermatitis

The Pathogenesis of Inflammatory Dermatologic Disorders and Rationale for Targeted Biologic Therapy

Prurigo Nodularis: Emerging Evidence on Disease Pathophysiology and Treatment

Watch Drs. Mease & Deodhar discuss #PsoriaticArthritis at #ACR25 - https://bit.ly/PSAChicago25-Y

IDEF: Expanding AD Options for Adults and Pediatric Patients 12 Years of Age and Older With Moderate

4 Hours Chopin for Studying, Concentration & Relaxation

Updates on Atopic Dermatitis Treatment Options and the Role of Biologics

IL 31 Mechanism of Action and Clinical Implications for Prurigo Nodularis

Watch Drs. Kushner & Kwo discuss #HVB updates from #TLM25 - visit: https://bit.ly/HepB25-Y

Biologics: The Solution for Psoriasis? | Anthony Fernandez, MD

Nowoczesne terapie w alergologii - leki biologiczne nadzieją dla chorych.

Atopic Dermatitis: Improving Outcomes in Adult and Pediatric Patients

Advances in the Management of Moderate to Severe Atopic Dermatitis

Watch Drs. Gillmore & Maurer discuss #ATTRCA updates - https://bit.ly/ATTR-Y

Under My Skin Eczema Documentary

Atopic Dermatitis – An Immunologist Perspective By Dr. Mohammed Maki

Webinar: Treatment of Moderate-to-Severe Atopic Dermatitis

Watch Dr. McConathy & co-chair discuss #AlzheimersDisease at #RSNA25 https://bit.ly/2025AD-Y

Fibrosing ILDs: Pulmonologist Conversations on Timely Diagnosis and Antifibrotic Therapy

Атопический дерматит от доктора Ахмеда Нуха

Refundowane terapie atopowego zapalenia skóry (AZS). Stan na grudzień 2022 roku.